Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease DOI Creative Commons
Lesley Jones, Peter Holmans, Marian L. Hamshere

et al.

PLoS ONE, Journal Year: 2010, Volume and Issue: 5(11), P. e13950 - e13950

Published: Nov. 15, 2010

Background Late Onset Alzheimer's disease (LOAD) is the leading cause of dementia. Recent large genome-wide association studies (GWAS) identified first strongly supported LOAD susceptibility genes since discovery involvement APOE in early 1990s. We have now exploited these GWAS datasets to uncover key pathophysiological processes. Methodology applied a recently developed tool for mining data biologically meaningful information dataset. The principal findings were then tested an independent Principal Findings found significant overrepresentation signals pathways related cholesterol metabolism and immune response both two largest LOAD. Significance Processes innate previously been implicated by pathological epidemiological disease, but it has unclear whether those reflected primary aetiological events or consequences process. Our evidence from demonstrates that processes are aetiologically relevant, suggests they may be suitable targets novel existing therapeutic approaches.

Language: Английский

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy DOI
Chia‐Chen Liu, Takahisa Kanekiyo, Huaxi Xu

et al.

Nature Reviews Neurology, Journal Year: 2013, Volume and Issue: 9(2), P. 106 - 118

Published: Jan. 8, 2013

Language: Английский

Citations

2975

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis DOI
Bob Olsson,

Ronald Lautner,

Ulf Andréasson

et al.

The Lancet Neurology, Journal Year: 2016, Volume and Issue: 15(7), P. 673 - 684

Published: April 10, 2016

Language: Английский

Citations

1770

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease DOI
Kaj Blennow, Harald Hampel, Michael W. Weiner

et al.

Nature Reviews Neurology, Journal Year: 2010, Volume and Issue: 6(3), P. 131 - 144

Published: Feb. 16, 2010

Language: Английский

Citations

1760

Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease DOI Creative Commons
Jorge J. Palop, Jeannie Chin, Erik D. Roberson

et al.

Neuron, Journal Year: 2007, Volume and Issue: 55(5), P. 697 - 711

Published: Sept. 1, 2007

Language: Английский

Citations

1538

Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks DOI
Jorge J. Palop, Lennart Mucke

Nature Neuroscience, Journal Year: 2010, Volume and Issue: 13(7), P. 812 - 818

Published: June 25, 2010

Language: Английский

Citations

1489

Role of ROS and RNS Sources in Physiological and Pathological Conditions DOI Creative Commons
S. Di Meo, Tanea T. Reed, Paola Venditti

et al.

Oxidative Medicine and Cellular Longevity, Journal Year: 2016, Volume and Issue: 2016(1)

Published: Jan. 1, 2016

There is significant evidence that, in living systems, free radicals and other reactive oxygen nitrogen species play a double role, because they can cause oxidative damage tissue dysfunction serve as molecular signals activating stress responses that are beneficial to the organism. Mitochondria have been thought both major role provide protection against excessive through several mechanisms, including stimulation of opening permeability transition pores. Until recently, functional significance ROS sources different from mitochondria has received lesser attention. However, most recent data, besides confirming mitochondrial protection, show interplay between cellular sources, so activation one lead sources. Thus, it currently accepted various conditions all contribution processes oxidatively tissues assure their survival, mechanisms such autophagy apoptosis.

Language: Английский

Citations

1398

Clearance systems in the brain—implications for Alzheimer disease DOI

Jenna M. Tarasoff-Conway,

Roxana O. Carare, Ricardo S. Osorio

et al.

Nature Reviews Neurology, Journal Year: 2015, Volume and Issue: 11(8), P. 457 - 470

Published: July 21, 2015

Language: Английский

Citations

1382

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention DOI Creative Commons
Chengxuan Qiu, Miia Kivipelto, Eva von Strauss

et al.

Dialogues in Clinical Neuroscience, Journal Year: 2009, Volume and Issue: 11(2), P. 111 - 128

Published: June 30, 2009

More than 25 million people in the world today are affected by dementia, most suffering from Alzheimer's disease. In both developed and developing nations, disease has had tremendous impact on individuals, caregivers, society. The etiological factors, other older age genetic susceptibility, remain to be determined. Nevertheless, increasing evidence strongly points potential risk roles of vascular factors disorders (eg, cigarette smoking, midlife high blood pressure obesity, diabetes, cerebrovascular lesions) possible beneficial psychosocial education, active social engagement, physical exercise, mentally stimulating activity) pathogenetic process clinical manifestation dementing disorders. long-term multidomain interventions toward optimal control multiple maintenance socially integrated lifestyles activities expected reduce or postpone onset including

Language: Английский

Citations

1126

Automatic classification of MR scans in Alzheimer's disease DOI Creative Commons
Stefan Klöppel, Cynthia M. Stonnington, Carlton Chu

et al.

Brain, Journal Year: 2008, Volume and Issue: 131(3), P. 681 - 689

Published: Jan. 18, 2008

To be diagnostically useful, structural MRI must reliably distinguish Alzheimer's disease (AD) from normal aging in individual scans. Recent advances statistical learning theory have led to the application of support vector machines for detection a variety states. The aims this study were assess how successfully assigned diagnoses and determine whether data-sets combined multiple scanners different centres could used obtain effective classification We linear classify grey matter segment T1-weighted MR scans pathologically proven AD patients cognitively elderly individuals obtained two with scanning equipment. Because clinical diagnosis mild is difficult we also tested ability differentiate control without post-mortem confirmation. Finally sought use these methods between suffering those frontotemporal lobar degeneration. Up 96% verified correctly classified using whole brain images. Data achieving comparable results separate analyses. Importantly, data one centre train machine accurately ageing another subjects scanner Patients mild, clinically probable age/sex matched controls separated 89% cases which compatible published rates best centres. This method confirmed either or degeneration their respective group. Our leads three conclusions: Firstly, healthy subjects. Secondly, they perform well differential forms dementia. Thirdly, robust can generalized across suggests an important role computer based diagnostic image analysis practice.

Language: Английский

Citations

1112

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy DOI
Guojun Bu

Nature reviews. Neuroscience, Journal Year: 2009, Volume and Issue: 10(5), P. 333 - 344

Published: April 2, 2009

Language: Английский

Citations

1082